Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/5205
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | He, Pandi | - |
dc.contributor.author | Yu, Leilei | - |
dc.contributor.author | Tian, Fengwei | - |
dc.contributor.author | Zhang, Hao | - |
dc.contributor.author | Chen, Wei | - |
dc.contributor.author | Zhai, Qixiao | - |
dc.date.accessioned | 2023-08-02T01:45:43Z | - |
dc.date.available | 2023-08-02T01:45:43Z | - |
dc.date.issued | 2022 | - |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/5205 | - |
dc.description.abstract | It is widely believed that diet and the gut microbiota are strongly related to the occurrence and progression of inflammatory bowel disease (IBD), but the effects of the interaction between dietary patterns and the gut microbiota on IBD have not been well elucidated. In this article, we aim to explore the complex relation between dietary patterns, gut microbiota, and IBD. We first comprehensively summarized the dietary patterns associated with IBD and found that dietary patterns can modulate the occurrence and progression of IBD through various signaling pathways, including mammalian target of rapamycin (mTOR), mitogen-activated protein kinases (MAPKs), signal transducer and activator of transcription 3 (STAT3), and NF-κB. Besides, the gut microbiota performs a vital role in the progression of IBD, which can affect the expression of IBD susceptibility genes, such as dual oxidase 2 (DUOX2) and APOA-1 , the intestinal barrier (in particular, the expression of tight junction proteins), immune function (especially the homeostasis between effector and regulatory T cells) and the physiological metabolism, in particular, SCFAs, bile acids (BAs), and tryptophan metabolism. Finally, we reviewed the current knowledge on the interaction between dietary patterns and the gut microbiota in IBD and found that dietary patterns modulate the onset and progression of IBD, which is partly attributed to the regulation of the gut microbiota (especially SCFAs-producing bacteria and Escherichia coli). Faecalibacteria as “microbiomarkers” of IBD could be used as a target for dietary interventions to alleviate IBD. A comprehensive understanding of the interplay between dietary intake, gut microbiota, and IBD will facilitate the development of personalized dietary strategies based on the regulation of the gut microbiota in IBD and expedite the era of precision nutritional interventions for IBD | en_US |
dc.language.iso | en | en_US |
dc.publisher | Oxford University Press on behalf of the American Society for Nutrition 2022 | en_US |
dc.subject | dietary patterns | en_US |
dc.subject | gut microbiota, | en_US |
dc.subject | short chain fatty acids | en_US |
dc.subject | bile acids | en_US |
dc.subject | tryptophan, | en_US |
dc.subject | inflammatory bowel disease | en_US |
dc.subject | dysbacteriosis | en_US |
dc.title | Dietary Patterns and Gut Microbiota: The Crucial Actors in Inflammatory Bowel Disease | en_US |
dc.type | Article | en_US |
Appears in Collections: | VOL 13 NO 5 2022 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
1628-1651.pdf | 2.35 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.